HistoRX


	Rx SERVICES & PARTNERING Drug Discovery & Development Disease Detection & Diagnosis Clinical Pathology & Patient Care

Rx SERVICES & PARTNERING
HistoRx Quantitative Tissue Biomarker Analysis

Our services generate incomparable quantitative data from the analysis of protein biomarkers in tissue to drive earlier decision making, improve efficiency and cost-effectiveness across the drug development continuum, and optimize drug approval success rates
Collaborations with pharmaceutical and biotechnology partners lead to the development of companion diagnostics linked to therapeutic drug candidates in our partners’ R&D pipelines

Value-Added PROGRAMS:

HistoRx quantitative biomarker analysis streamlines drug development and increases FDA approval success rate
Patient selection for targeted therapy via companion diagnostic = maximized market share

DISCOVERY

PRECLINICAL R&D

CLINICAL

FDA APPROVAL

Target discovery

Target validation

Drug candidate validation

Animal model validation

Dose selection

Predictive toxicology

Predict drug effectiveness

Clinical trial entry criteria

Patient stratification

Patient monitoring

Drug response prediction

Optimize patient selection

Decrease adverse experience

Improve cost/benefit ratio

Optimize market share